Announce Date | 08/04/2025 |
EPS Normalized Actual | $0.6 (Beat by $0.53) |
EPS GAAP Actual | $0.6 (Beat by $0.53) |
Revenue Actual | $0.081755B |
Revenue Surprise | Beat by $81.755M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.35675 |
EPS GAAP Estimate | $0.35675 |
Revenue Estimate | $0.064476B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 2 | 12.86 | 1.96296 | 2.03704 | 1 |
Dec 2028 | 2.3 | 11.18 | 2.1936 | 2.38513 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.62 | 0.62 | 0.081755B | 18.54% | 81.76M |
FQ1 2025 (Mar 2025) | 0.08 | 0.08 | 0.066171B | 7.52% | 66.17M |
FQ4 2024 (Dec 2024) | 0 | 0 | 0.055926B | 100% | 55.93M |
FQ3 2024 (Sep 2024) | 0.58 | 0.58 | 0.05828B | 100% | 58.28M |
FQ1 2021 (Feb 2021) | -0.0201 | -0.0201 | 0.0346695B | 100% | 34.67M |
FQ2 2021 (May 2021) | -0.0201 | -0.0201 | 0.0346695B | 100% | 34.67M |
FQ3 2021 (Aug 2021) | 0.0229 | 0.0229 | 0.055143B | 100% | 55.14M |
FQ1 2022 (Mar 2022) | -0.0163 | -0.0163 | 0.064979B | 46.65% | 64.98M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
0.35675
Consensus Revenue Estimates
0.064476B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.54 | -- | 0.46017 | 0.60328 | 0 |
FQ3 2027 (Sep 2027) | 0.53 | -- | 0.45165 | 0.5921 | 0 |
FQ2 2027 (Jun 2027) | 0.51 | -- | 0.43461 | 0.56976 | 0 |
FQ1 2027 (Mar 2027) | 0.5 | -- | 0.42609 | 0.55859 | 0 |
FQ4 2026 (Oct 2026) | 0.4265 | -- | 0.40766 | 0.44764 | 0 |
FQ3 2026 (Jul 2026) | 0.4101 | -- | 0.39199 | 0.43043 | 0 |
FQ2 2026 (Jun 2026) | 0.412 | -50.49 | 0.38406 | 0.44593 | 0 |
FQ1 2026 (Mar 2026) | 0.4111 | 80.54 | 0.38322 | 0.44495 | 0 |
FQ4 2025 (Oct 2025) | 0.41883 | -- | 0.40033 | 0.43959 | 1 |
FQ3 2025 (Sep 2025) | 0.35675 | -62.58 | 0.33256 | 0.38613 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 0.09B | -- | 0.08B | 0.1B | 1 |
FQ3 2027 (Sep 2027) | 0.09B | -- | 0.08B | 0.1B | 1 |
FQ2 2027 (Jun 2027) | 0.09B | -- | 0.08B | 0.1B | 1 |
FQ1 2027 (Mar 2027) | 0.09B | -- | 0.08B | 0.1B | 1 |
FQ4 2026 (Oct 2026) | 0.1B | -- | 0.1B | 0.1B | 1 |
FQ3 2026 (Jul 2026) | 0.1B | -- | 0.09B | 0.1B | 1 |
FQ2 2026 (Jun 2026) | 0.24B | 66.3 | 0.23B | 0.26B | 1 |
FQ1 2026 (Mar 2026) | 0.23B | 70.62 | 0.21B | 0.24B | 1 |
FQ4 2025 (Oct 2025) | 0.07B | 16.61 | 0.06B | 0.07B | 0 |
FQ3 2025 (Sep 2025) | 0.06B | 9.61 | 0.06B | 0.07B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
3
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 0.62 | 0.62 | 100% | |
FQ1 2025 (Mar 2025) | 0.08 | 0.08 | 100% | |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 0.58 | 0.58 | 100% | |
FQ1 2021 (Feb 2021) | -0.0201 | -0.0201 | 100% | |
FQ2 2021 (May 2021) | -0.0201 | -0.0201 | 100% | |
FQ3 2021 (Aug 2021) | 0.0229 | 0.0229 | 100% | |
FQ1 2022 (Mar 2022) | -0.0163 | -0.0163 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $0B | $0.08B | $81.76M | 100% |
FQ1 2025 (Mar 2025) | $0B | $0.07B | $66.17M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.06B | $55.93M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.06B | $58.28M | 100% |
FQ1 2021 (Feb 2021) | $0B | $0.03B | $34.67M | 100% |
FQ2 2021 (May 2021) | $0B | $0.03B | $34.67M | 100% |
FQ3 2021 (Aug 2021) | $0B | $0.06B | $55.14M | 100% |
FQ1 2022 (Mar 2022) | $0B | $0.06B | $64.98M | 100% |